TherapeuticsMD (TXMD) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
TherapeuticsMD Announces Third Quarter 2018 Financial Results
November 7, 2018 4:05 PM EST-Strong early launch indicators for IMVEXXY-
-BIJUVA commercial launch planned for 2Q 2019-
-ANNOVERA commercial launch planned for 4Q 2019-
-Conference call scheduled for 4:30 p.m. ET today-
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative womens healthcare company, today announced its clinical and corporate update for the quarter ended September 30, 2018.
We are extremely pleased with the momentum of the IMVEXXY launch, including our progress with negotiating commercial payer coverage, said Robert G. Finizio, Chief... More
